My Curriculum Vitae

Education and Certification

American Board of Forensic Toxicology
     Diplomate of the ABFT - Forensic Toxicology (D-ABFT-FT)
     License 1285
          Acquired: August 2012
          Requalification: December 2017

Master of Science, Forensic Toxicology (Veterinary Medical Sciences)
     University of Florida
          Gainesville, FL 32611

Bachelor of Arts, Biology
     Franklin College
          Franklin, IN 46143

Professional Experience

Axis Forensic Toxicology
     Indianapolis, IN 46278
          Senior Forensic Toxicologist (07/2016 - Present)

American Institute of Toxicology
     Indianapolis, IN 46241
          Forensic Toxicologist (05/2011 - 07/2016)
          Assistant Technical Director (04/2010 - 05/2011)
          Laboratory Manager - Mass Spectrometry Screening / Esoteric Testing (03/2009 - 04/2010)
          Laboratory Manager - Forensics (05/2008 - 03/2009)
          Senior Chemist - Research and Development (05/2006 - 05/2008)
          Analytical Chemist - Research and Development (05/2003 - 05/2006)

Professional Affiliations

Society of Forensic Toxicologists (SOFT) - Full Member
     2008 - Present
    
          SOFT Designer Drugs Committee
             2017 - Present

          SOFT Young Forensic Toxicologists Committee
             2014 - Present

          SOFT ToxTalk "From the Toxicology Literature" Editor
             2015 - Present

American Academy of Clinical Toxicology (AACT)
     2015 - Present

Academic Research Projects

The Effects of Acquisition of Blood Specimens on Drug Levels and the Effects of Transportation Conditions on Degradation of Drugs. J. McLemore, E.W. Schwilke, K. Shanks, D. Klein. 244230, 2010-DN-BX-K216. U.S. Department of Justice.

Peer Reviewed Publications

Detection of Carfentanil by LC-MS-MS and Reports of Associated Fatalities in the USA. K. Shanks, G. Behonick. Journal of Analytical Toxicology (2017)

Carfentanil Identified in Two Driving Under the Influence of Drugs Cases. N.B. Tiscione, K. Shanks. ToxTalk, Society of Forensic Toxicologists, Inc. (2016)

Rapid Screening and Identification of Novel Psychoactive Substances Using Paper Spray Interfaced to High Resolution Mass Spectrometry. J. Kennedy, K. Shanks, K. Van Natta, M.C. Prieto Conaway, J.M. Wiseman, B. Laughlin, M. Kozak. Clinical Mass Spectrometry (2016)

Synthetic Cannabinoid Product Surveillance by LC/ToF in 2013-2015. K. Shanks, G. Behonick. Journal of Forensic Toxicology and Pharmacology (2016)

Death After the Use of the Synthetic Cannabinoid 5F-AMB. K. Shanks, G. Behonick. Forensic Science International (2016)

Death Associated with the Use of the Synthetic Cannabinoid ADB-FUBINACA. K. Shanks, W. Clark, G. Behonick. Journal of Analytical Toxicology (2016)

Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014. K. Shanks, T. Sozio, G. Behonick. Journal of Analytical Toxicology (2015)

Case Reports of Synthetic Cannabinoid XLR-11 Associated Fatalities. K. Shanks, D. Winston, J. Heidingsfelder, G. Behonick. Forensic Science International (2015)

Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid 5F-PB-22. G. Behonick, K. Shanks, D. Firchau, G. Mathur, C. Lynch, M. Nashelsky, D. Jaskierny, C. Meroueh. Journal of Analytical Toxicology (2014)

A Guide for the Interpretation of Postmortem Methamphetamine Findings: A Series of Case Reports. K. Quigley, K. Shanks, G. Behonick, A. Terrell. Journal of Forensic Toxicology and Pharmacology (2014)

Identification of Novel Third Generation Synthetic Cannabinoids in Products by Ultra Performance Liquid Chromatography with Time of Flight Mass Spectrometry. K. Shanks, T. Dahn, G. Behonick, A. Terrell (2013)

Detection of Synthetic Cannabinoids and Synthetic Stimulants in First and Second Generation Legal Highs by Ultra Performance Liquid Chromatography with Time of Flight Mass Spectrometry (UPLC/ToF). K. Shanks, T. Dahn, G. Behonick, A. Terrell. Journal of Analytical Toxicology (2012)

Detection of JWH-018 and JWH-073 by UPLC/MS/MS in Postmortem Whole Blood Casework. K. Shanks, T. Dahn, A. Terrell. Journal of Analytical Toxicology (2012)

Oral Presentations and Invited Talks


LC/ToF Method Development and Validation
Toxicology Method Development and Validation Workshop – California Office of Traffic Safety
Rancho Cordova, CA (2017)

Fentanyl Analogs and Designer Opioids: To Go Where No One Has Gone Before
Missouri Medical Examiner and Coroner’s Training Conference, Jefferson City, MO (2017)

Not Your Father’s Heroin: Fentanyl and Analogs
Kentucky Coroner’s Association Annual Training Meeting, Louisville, KY (2017)

Synthetic Cannabinoids: Here Today, Gone Tomorrow
Midwest Association of Toxicology and Therapeutic Drug Monitoring Annual Meeting, Rosemont, IL (2017)

LC/ToF Method Development and Validation
Toxicology Method Development and Validation Workshop – California Office of Traffic Safety
Santa Ana, CA (2017)

New Psychoactive Substances: Synthetic Cannabinoids to Fentanyl Analogs.
Illinois Coroner and Medical Examiner’s Association, Peoria, IL (2016)

Forensic Chemistry Reddit AMA (Ask Me Anything): American Chemical Society, National Chemistry Week (2016)  https://www.reddit.com/r/science/comments/583fbs/american_chemical_society_ama_hi_reddit_im_kevin/

New Psychoactive Substances: Synthetic Cannabinoids to Fentanyl Analogs
Forensic Science Seminar, Minneapolis, MN (2016)

The Every Changing Scope of  Synthetic Cannabinoids in Toxicology Casework (2011-2015)
Society of Forensic Toxicologists, Dallas, TX (2016)

The Current Heroin and Fentanyl Analog Epidemic: A Toxicological Perspective.
Medicolegal Death Investigator Training, Indiana Coroner’s Association, Indianapolis, IN (2016)

Toxicology: Trials and Tribulations
Regional Drugged Driving Summit, AAA and the Ohio Department of Public Safety, Blue Ash, OH (2016)

New Psychoactive Substances: From Synthetic Cannabinoids to Fentanyl Analogs
Wyoming Coroner’s Association. Coroner’s Conference, Sheridan, WY (2016)

An Introduction and Case Study Related to NBOMes
AIT Laboratories Webinar, Indianapolis, IN (2016)

New Psychoactive Substances: The Present and the Future
California Association of Toxicologists Conference, Lake Tahoe, NV (2016)

Synthetic Cannabinoids: A Primer
AIT Laboratories Webinar, Indianapolis, IN (2016)

Three Fatalities Associated with the Synthetic Cannabinoid AB-CHMINACA
Society of Forensic Toxicologists, Atlanta, GA (2015)

Instrumentation in the Forensic Toxicology Laboratory: Advantages and Disadvantages
Society of Forensic Toxicologists, Atlanta, GA (2015)

Deaths Associated With Synthetic Cannabinoids in the USA
Florida Association of Medical Examiner’s Annual Meeting, Daytona Beach, FL (2015)

Postmortem Toxicology: Specimen Selection, Drug Trends, and The Future
Kentucky Coroner’s Association Annual Conference, Louisville, KY (2015)

Case Reports: Fatalities Associated with the Synthetic Cannabinoid, AB-PINACA
Society of Forensic Toxicologists, Grand Rapids, MI (2014)

Introduction to Forensic Toxicology
Indiana Academy of Mathematics and Sciences, Muncie, IN (2013)

Designer Drugs: From Product Surveillance to Forensic Casework
Michigan Association of Medical Examiners Conference, Mt. Pleasant, MI (2013)

The Forensics of Drug Diversion and Synthetic Drugs
International Symposium on Safe Medicine, Charleston, WV (2013)

Designer Drugs: Synthetic Cannabinoids, Stimulants, and Psychedelics
American Academy of Family Physicians, Corporate Health Directors Network, Washington, D.C. (2013)

K2, Bath Salts and Emerging Toxicology Trends in the Midwest
Iowa Association of County Medical Examiners’ Fall Meeting and Education Expo, Des Moines, IA (2012)

Designing Disaster:  The History of the Designer Drug Movement, 1960s to Present
Forensic Science Lecture Series.  Indiana Medical History Museum (2012)

Analytical Challenges of Synthetic Cannabinoids
Pharmacology Workshop.  Midwest Association of Forensic Scientists, Milwaukee, WI (2012)

Drug Facilitated Sexual Assault
St. Franciscan Sexual Assault Nurse Examiners (SANE) training (2012)

New Designer Drugs – Synthetic Cannabinoids and Synthetic Stimulants
Indiana Coroner’s Association, Coroner’s Conference, Merillville, IN (2012)

New Designer Drugs – Synthetic Cannabinoids and Synthetic Stimulants
Colorado Coroner’s Association, Coroner’s Conference, Pueblo, CO (2012)

New Designer Drugs – Synthetic Cannabinoids and Synthetic Stimulants
Wyoming Coroner’s Association, Coroner’s Conference, Sheridan, WY (2012)

Drug Facilitated Sexual Assault
St. Franciscan Sexual Assault Nurse Examiners (SANE) training (2011)

New Designer Drugs – Synthetic Cannabinoids and Synthetic Stimulants
Kentucky Coroner’s Association, Drug Death Investigation Course, Lake Barkley, KY (2011)

General Unknown Screening Using ToF-MS: A Reference Lab Perspective
The Association for Mass Spectrometry: Applications to the Clinical Laboratory, San Diego, CA (2011)

Nonroutine Case Studies in Forensic Toxicology
Butler University, Indianapolis, IN. Chemistry Seminar (2010)

UPLC/MS Applications in Forensic Toxicology
Midwest Association of Forensic Scientists, Des Moines, IA (2008)

UPLC and Time of Flight Mass Spectrometry for Unknown Screening in Forensic Toxicology
Waters UPLC Symposium, Indianapolis, IN (2007)
 
Poster Presentations

Analysis of AB-CHMINACA in Hair by Solid Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry”, C. Soni, D. Engelhart, E.S. Lavins, K. Shanks, C.K. Naso-Kaspar, T.P. Gilson – Midwest Association of Toxicology and Therapeutic Drug Monitoring, Milwaukee, WI (2016)

Detection of Synthetic Cannabinoids in Two E-Cigarette Liquids. K. Shanks – Society of Forensic Toxicologists, Atlanta, GA (2015)

Postmortem Tissue Distribution of AB-CHMINACA Following Lethal Intoxication Compared with AB-CHMINACA Concentrations in Impaired Drivers. E.S. Lavins, K. Shanks, D.E. Englehart, H.E. Schueler, D.A. Galita, A.D. McCollum, C.H. Soni, P.D. Boggs, D.E. Rohde, C.K Naso-Kaspar, S. Sofalvi, M. Hansbrough, C. Carroll-Pankhurst, T.P Gilson. – Society of Forensic Toxicologists, Atlanta, GA (2015)

Rapid Screening and Identification of Designer Drugs in Powders or Plant Materials Using Paper Spray Ionization-Mass Spectrometry. J.H. Kennedy, K. Shanks, K. Van Natta, M.C. Prieto Conaway, B. Laughlin, J.M. Wiseman, M. Kozak – American Association for Mass Spectrometry, St. Louis, MO (2015)

Evaluation of Postmortem Methamphetamine Concentrations: A Series of Case Studies. K.M. Kitts, G.S. Behonick, K. Shanks – American Academy of Forensic Sciences, Seattle, WA (2014)
 
Detection of Alpha-PVP in Postmortem Blood Casework by UPLC/MS/MS. K. Shanks, G. Behonick, A. Terrell - Society of Forensic Toxicologists, Orlando, FL (2013)

Case Report: Identification of 8-hydroxyquinoline Cannabinoids in Herbal Products. K. Shanks, G.S. Behonick, A.R. Terrell – Society of Forensic Toxicologists, Orlando, FL (2013)

Evaluation of Postmortem Methamphetamine Concentrations. K. Kitts, G. Behonick, K. Shanks – Midwest Association of Forensic Scientists, Dayton, OH (2013)

Death by ‘Legal Psychedelic Phenethylamines’: Postmortem Tissue Distribution of Desoxypipradrol (2-DPMP) and 4-chloro-2,5-dimethoxyamphetamine (DOC). E.S. Lavins, M. Pietrangelo, K. Shanks, C. Cushman, S. Sofalvi, J. Felo, J.F. Wyman, T.P. Gilson - American Academy of Forensic Sciences, Washington D.C. (2013)

Methylenedioxypyrovalerone (MDPV) Postmortem Blood Concentrations: A Series of Suicide Case Reports. G. Behonick, K. Shanks, A.R. Terrell – American Academy of Forensic Sciences, Washington, D.C. (2013)

A Dual Quantitative/Qualitative Screening Analysis for 32 Antidepressants and Metabolites in Human Urine by UPLC/ToF. K. Shanks, T. Dahn, A. Terrell – Society of Forensic Toxicologists, Richmond, VA (2010)

Analysis of Prilocaine in Postmortem Whole Blood and Vitreous Fluid Utilizing UPLC/ToF (Screening) and UPLC/MS/MS (Confirmation). M. Klebs, K.Shanks, A. Terrell – Midwest Association of Forensic Science, Des Moines, IA (2008)
 
A Rapid General Unknown Screen in Blood by Ultra Performance Liquid Chromatography and Time of Flight Mass Spectrometry. K. Shanks, T. Dahn, M. Larson, A. Terrell - American Association of Clinical Chemistry, Washington, D.C. (2008)

Screening of Postmortem Specimens for Drugs of Abuse and Therapeutic Drugs by UPLC/ToF. K. Shanks, T. Dahn, M. Larson, A. Terrell, J. Bohuslavek – Society of Forensic Toxicologists, Raleigh-Durham, NC (2007)

Quantitation of Seven Opioids in Urine Utilizing HPLC-MS/MS”. T. Dahn, K. Shanks, A. Terrell, T. Sasaki – Society of Forensic Toxicologists, Austin, TX (2006)

Evaluation of a LC/MS Method to Screen For Drugs in Postmortem Whole Blood Specimens. K. Shanks, T. Dahn, A. Terrell, J. Bohuslavek – Society of Forensic Toxicologists, Austin, TX (2006)